Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles

Acta Pharmacologica Sinica

Volumn 26, Issue 12, 2005, Pages 1512-1518

  Huang, Min ^a   Wu, Wei ^a   Qian, Jun ^a   Wan, Dan Jing ^a   Wei, Xiu Li ^a   Zhu, Jian Hua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cynoacrylates; Nanotechnology; Polyethylene glycols; Polymers; Spleen; Tissue distribution

Indexed keywords

COPOLYMER; CYANOACRYLATE DERIVATIVE; METHOXYPOLYETHELYNE GLYCOL CYANOACETATE; NANOPARTICLE; POLY(EHTHYLENE GLYCOL) CYANOACRYLATE CO N HEXADECYL CYANOACRYLATE; POLYETHYLENE DERIVATIVE; RHODAMINE B; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; BODY DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; RADIOACTIVITY; SCINTILLATION;

ANIMALS; CYANOACRYLATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MACROPHAGES, PERITONEAL; MICE; NANOPARTICLES; PARTICLE SIZE; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; SPLEEN; TISSUE DISTRIBUTION;

EID: 29044448714     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00216.x     Document Type: Article

References (20)

1. Makino K, Yamamoto N, Higuchi K, Harada N, Ohshima H, Terada H. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloid Surf B 2003; 27: 33-9.
2. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003; 42: 463-78.
3. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001; 53: 283-318.
4. Neradovic D, Soga O, Nostrum CFV, Hennink WE. The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials 2004; 25: 2409-18.
5. Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 2000; 18: 412-20.
6. Moghimi SM. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block copolymers. Adv Drug Del Rev 1995; 16: 183-93.
7. Vandorpe J, Schacht E, Dunn S, Hawley A, Stolnik S, Davis SS, et al. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly (ethylene oxide) copolymer. Biomaterials 1997; 18: 1147-52.
8. Wilkins DJ, Myers PA. Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat. Br J Exp Pathol 1966; 47: 568-76.
9. Peracchia MT, Fattal E, Desmaele D, Besnard M, Noel JP, Gomis MJ, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 1999; 60: 121-8.
10. Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan WF, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 2001; 71: 203-11.
11. Huang M, Wu W. Synthesis of poly [poly (ethylene glycol)-cyanoacrylate- co-hexadecyl cyanoacrylate] used for the preparation of nanoparticles. Chin J Pharm 2005; 36: 152-5.
12. Nam YS, Kang HS, Park JY, Park TG, Han SH, Chang IS. New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials 2003; 24: 2053-9.
13. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000; 18: 301-13.
14. Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000; 202: 1-10.
15. Nguyen CA, Allémann E, Schwash G, Doelker E, Gurny R. Cell interaction studies of PLA-MePEG nanoparticles. Int J Pharm 2003; 254: 69-72.
16. Bocca C, Caputo O, Cavalli R, Gabriel L, Miglietta A, Gasco MR. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm 1998; 175: 185-93.
17. Illum L, Hunneyball IM, Davis SS. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Pharm 1986; 29: 53-65.
18. Moghimi SM. Mechanisms of splenic clearance of blood cells and particles-towards development of splenotropic agents. Adv Drug Del Rev 1995; 17: 103-15.
19. Moghimi SM, Porter CJH, Muir IS, Illum L, Davis SS. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991; 177: 861-6.
20. Moghimi SM, Hedeman H, Muir IS, Illum L, Davis SS. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochem Biophys Acta 1993; 1157: 233-40.